Clinical trial Recruiting at 3 sites Observational Ages 18 to 45 Women only

Assessing heart disease and diabetes risk in women during and after pregnancy

Official title: Preconception to pOst-partum Study of Cardiometabolic Health in Primigravid PregnancY

Run by Cambridge University Hospitals NHS Foundation Trust · NCT05856318 · Data updated 2026-11-12

This study is trying to see how pregnancy complications like pre-eclampsia affect women's chances of developing heart disease and diabetes later on, by following women who are trying to get pregnant and comparing them to those who aren't.

More Diabetes trials

Quick facts

Study typeObservational
Ages18 Years to 45 Years
SexWomen only
Enrollment3500 (estimated)
SponsorCambridge University Hospitals NHS Foundation Trust
Academic / other
Locations7 sites (Cambridge and 6 other locations)
StatusRecruiting
StartedMay 24, 2023
Main results expectedDecember 2027
Study endsDecember 2052
Registry record updatedApril 9, 2024
Trial IDNCT05856318 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are nulliparous women aged 18 to 45 who are actively considering pregnancy within the next year.

Probably not a fit

Patients currently pregnant, those with established infertility, or individuals with certain chronic conditions will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on women who experience placental complications during pregnancy, such as pre-eclampsia and gestational hypertension, to evaluate their risk factors for developing heart disease and diabetes. The study will recruit women actively trying to conceive and follow them through their pregnancy and up to 12 months postpartum. Additionally, a control group of women not planning pregnancy will be included to compare outcomes. The goal is to understand how placental syndromes impact long-term cardiovascular health and to identify potential preventive measures.

Why it matters

Potential benefit: If successful, this study could lead to improved strategies for reducing the risk of heart disease and diabetes in women who experience placental syndromes.

How similar studies have gone: Other studies have indicated significant associations between placental syndromes and long-term cardiovascular risks, suggesting this approach is grounded in existing evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Pregnancy Arm Inclusion Criteria:

To be included in the trial the participant must:

* Nulliparous (no previous pregnancy beyond 20 weeks' gestation)
* Actively considering pregnancy within approximately 12 months
* Aged between 18 and 45 years
* Ability to consent and willing to participate

Pregnancy Arm Exclusion Criteria:

The presence of any of the following will preclude participant inclusion:

* Currently pregnant
* Established infertility
* Planning or actively using fertility treatments (e.g. IVF, ICSI, FET, IUI)
* Assigned male sex at birth
* Autoimmune disease (e.g. rheumatoid arthritis, lupus)
* Thrombophilia
* Type 1 diabetes
* Known advanced chronic kidney disease (stages 4-5)
* Malignant hypertension
* Clinically manifest CVD (e.g. previous myocardial infarction, stroke)
* Active cancer/being treated for cancer currently (other than skin cancer)
* Any other condition preventing full participation in the study

Non-Pregnancy Arm Inclusion criteria

To be included in the trial the participant must:

* Nulliparous (no previous pregnancy beyond 20 weeks' gestation)
* Not planning to conceive during next 18 months
* Aged between 18 and 45 years
* Ability to consent and willing to participate

Non-Pregnancy Exclusion Criteria

The presence of any of the following will preclude participant inclusion:

* Currently pregnant
* Planning or actively using fertility treatments (e.g. IVF, ICSI, FET, IUI)
* Assigned male sex at birth
* Autoimmune disease (e.g. rheumatoid arthritis, lupus)
* Thrombophilia
* Type 1 diabetes
* Known advanced chronic kidney disease (stages 4-5)
* Malignant hypertension
* Clinically manifest CVD (e.g. previous myocardial infarction, stroke)
* Active cancer/being treated for cancer currently (other than skin cancer)
* Any other condition preventing full participation in the study

Where it's running

  • Cambridge University Hospitals NHS Foundation Trust
    Cambridge, United Kingdom
    Recruiting
  • NHS Greater Glasgow and Clyde
    Glasgow, United Kingdom
    Recruiting
  • Imperial College Healthcare NHS Trust
    London, United Kingdom
    Recruiting
  • University College London Hospitals NHS Foundation Trust
    London, United Kingdom
    Not yet recruiting
  • King's College Hospital NHS Foundation Trust
    London, United Kingdom
    Not yet recruiting
  • St George's University Hospitals NHS Foundation Trust
    London, United Kingdom
    Not yet recruiting
Show 1 more location
  • Manchester University NHS Foundation Trust
    Manchester, United Kingdom
    Not yet recruiting

Study contacts

  • Principal investigator: Ian Wilkinson, MD — Cambridge University Hospitals NHS Foundation Trust
  • Study coordinator: Heike Templin
  • Email: cuh.poppycctu@nhs.net
  • Phone: 0044 1223 250874

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Assessing pancreas changes during pregnancy

    This study is testing how the size of the pancreas changes during pregnancy in women and their babies, especially looking at the effects of diabetes.

    Recruiting University of Texas at Austin · Austin, Texas · NCT06784674

  • Personalized dietary responses for better health

    This study is testing how different foods affect people's health based on their unique responses, and it's for individuals taking part in the ZOE testing program.

    Recruiting at 2 sites Zoe Global Limited · Needham, Massachusetts and 1 other locations · NCT04735835

  • Collection and storage of human biological samples for research

    This study is about collecting and storing biological samples from people with different health conditions to help researchers find better ways to prevent, diagnose, and treat diseases.

    Recruiting Chinese University of Hong Kong · Hong Kong · NCT04706481

  • Postpartum exercise to improve heart and metabolic health in women at high risk for preeclampsia

    This pilot study tests whether a 12‑week postpartum exercise program can improve heart health and metabolic markers in women who were at high risk for preeclampsia.

    Recruiting Chinese University of Hong Kong · Hong Kong, Hong Kong · NCT07921173

  • New virtual care pathway for older adults with chronic diseases

    A teleconsultation-based care pathway for adults 60+ with hypertension, diabetes, or dyslipidemia to see if it’s feasible and cost-saving in Malaysian primary care compared with usual clinic visits.

    Recruiting National University of Malaysia · Kuala Lumpur · NCT07843238

  • Benefits of Retained Insulin for Good Health in Diabetes

    This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.

    Recruiting at 4 sites Royal Devon and Exeter NHS Foundation Trust · Truro, Cornwall and 3 other locations · NCT07828626

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.